In an analysis of Tg doubling time (Tg-DT), which is the time required to double the amount of Tg, Rössing et al. (16) have suggested that Tg-DT is not a single predictor of progressive disease but that it creates significant differences in the survival of patients with high tumor burden in patients with progressive DTC. Here, TG is linked to neoplasm.